Background: Despite recent progress in survival times of xenografts in non-human
| INTRODUC TI ON
Organ shortage is a major obstacle in clinical transplantation. 1 Although lung transplantation is now widely accepted as the only successful treatment for end-stage lung disease, 2 there is a large and growing discordance between the number of patients on the waiting list and donor organ availability. 3 Recent progress in xenotransplantation (XTx) increases the likelihood that XTx may provide a practical means for overcoming this organ shortage.
Size and both physiologic and anatomic similarities between swine and humans, as well as the tractability of swine to genetic modification, have made this species the most attractive potential donor for clinical XTx. [4] [5] [6] The use of multitransgenic (Tg) swine donors has allowed survival of heterotopic hearts in baboons for over 2 years 7 and consistent survivals of life-supporting kidneys for greater than 6 months. 8, 9 However, the results for lung xenotransplantation (XLTx) in pig-to-baboon models remain limited, [10] [11] [12] with only rare and sporadic reports of survivals over 5 days. 13 Rejected lung grafts were hemorrhagic despite the use of multi-Tg donors, 14 and to our knowledge, there have been no published reports of histologically proven survivals over 7 days. These results suggest the presence of unique immunologic barriers in pig-to-primate XLTx.
In this study, we have attempted to prolong survival of porcine XLTx in baboons by combined strategies, consisting of (i) utilizing 4 different genetically modified porcine lungs, especially focusing on the role of hCD47 expression in donor lung grafts, and (ii) utilizing an induction immunosuppressive regimen that is similar to that of the xeno-kidney transplant model that has achieved an average of longer than 4-month survival of life-supporting GalT-KO alone kidney grafts in baboons. 15 In designing this strategy, we reasoned (i) that hCD47
expression might overcome problems caused by the known species incompatibility of porcine CD47 and the primate homolog of its ligand, signal regulatory protein alpha (SIRPα) [16] [17] [18] [19] and (ii) that hCD55 or hCD46 would mitigate the complement-mediated effects of natural anti-pig antibodies. We also tested whether vascularized thymic grafts from the same donors might facilitate prolonged xenograft lung survival by minimizing primate anti-pig T-cell responses.
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We have previously reported successful induction of tolerance by the transplantation of allogeneic VTL 23, 24 or thymokidneys (TK) 21, 25 as well as markedly prolonged survival of life-supporting porcine TKs in baboons. 26 Most recently, we have achieved greater-than-6-month survival of a life-supporting porcine TK with a modified immunosuppressive regimen. 15 Using this strategy, we report here >7-day survival with the histologic evidence of viable lung xenografts. Immunohistologic analysis of donor lungs demonstrated hCD47 expression both on endothelium and on alveolar epithelium only in lungs from donors that survived >7 days. All other donors lacked hCD47 expression on pulmonary endothelial cells and were completely rejected early with diffuse hemorrhagic changes and antibody/complement deposition.
Our data suggest that a unique immunologic environment exists in lungs and that hCD47 expression in both alveoli and vessels may play an important role in reducing immunologic damages that cause the early loss of lung xenografts.
| MATERIAL S AND ME THODS

| Animals
| Recipients
We used 11 baboons (Papio hamadryas) purchased from Mannheimer Foundation, Homestead, FL.
| Donors
We used 2 different strains of GalT-KO pigs. One was the Sachs/ Columbia GalT-KO, inbred miniature swine with or without genetic modification to carry hCD47 and hCD55 transgenes 27, 28 ( Figure 1 ).
Four F1-and F2-generation offspring of the founders of this line were used in this study. The other animals were outbred domestic swine provided by Revivicor Inc. (Blacksburg, VA) that carried either hCD46/hCD47 GalT-KO or GalT-KO/hCD39/hCD46/hCD55/ hTBM/hEPCR genetic modifications. To confirm the transgenic expression in donor lungs, contralateral right naïve lung tissues lungs are highly susceptible to acute humoral rejection and that this may be mitigated by transgenic expression of hCD47.
K E Y W O R D S
hCD47, lung transplantation, pig to baboon, xenotransplantation F I G U R E 1 pDAF (CD55)-CD47 expression vector for transgenic pig production. hCD47 and hCD55 expression cassettes are oriented in opposing directions. The hCD55 minigene is comprised of human genomic DNA including the native promoter/enhancer region, the 3′ UTR through the pA, exon 1, and intron 1. The coding sequence (CDS) was substituted for genomic sequences covering the remaining exons. A small segment of plasmid backbone follows the CD55 minigene (not shown) hCD47 CDS EF1α Promoter SV40 splice/pA hCD55 Minigene of donor pigs were collected and stained with anti-human CD39, hCD46, hCD47, hCD55, TBM, and EPCR abs ( 
| E XPERIMENTAL G ROUPS
| Non-survival procedure group
As the initial experiment, we performed 2 non-survival procedures to examine sequential changes of porcine lung grafts in baboons under general anesthesia for up to 72 hours after reperfusion, with ventilation.
| Survival procedure group
We next performed 9 survival procedures, in which recipients were sedated and maintained with ventilation support for 16 hours after reperfusion of lung xenografts and then weaned from ventilation.
In both non-survival and survival procedures, gross findings were noted, as well as graft PV gas analysis and tissue biopsy. If the graft could not be inflated and PF ratio (PaO2/FiO2: fractional inspired oxygen) of graft PV was <150 mm Hg, then the animal was killed. Details of monitoring are described in Supporting Information (Methods).
Details of donors, experimental groups, the immunosuppressive regimen, surgical procedures, histologic examination, flow cytometric analyses, and total and cytotoxic antibody assays are provided as Supporting Information.
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| RE SULTS
| A. Two non-survival procedures performed successfully as a pilot study
In our initial study, we performed 2 non-survival transplant procedures. Both cases were successfully completed without technical or anesthetic complications. Graft survivals for these 2 cases were 48 hours (Baboon ID #13P64) and >72 hours (13P85), respectively (Table 1 ). In the first procedure (13P64), both the left lung graft and the right native lung appeared well perfused and expanded ( Figure 2A ). The general status of the recipient, including oxygenation, was stable. One unit of packed red blood cells (pRBC) was transfused 2 hours after revascularization ( Figure 2B ). In addition, the PaO2 of the blood from the graft PV was stable, similar to systemic ABG ( Figure 2C ). However, at 48 hours post-reperfusion, the graft PA flow weakened and no blood could be taken from the graft PV, indicating graft rejection. Hemorrhagic changes and congestion were seen, both grossly and histologically ( Figure 2D ). For the 2nd case (13P85), due to the size of the donor, we used the left lower lobe for transplantation into a 7 kg baboon. Bullae did not develop, and the recipient maintained stable systolic blood pressure and SpO2 levels during the entire 72-hours follow-up period ( Figure 3A ).
The platelet counts did not decrease below 50K after revascularization ( Figure 3B ). The graft was aerated, and the PaO2 from the graft PV was continuously maintained >200 mm Hg throughout the transplant, until termination of the experiment at 72 hours postreperfusion ( Figure 3C ). However, histologic findings showed that although there were still patent small vessels and preservation of alveolar structure, some areas showed hemorrhagic changes and congestion ( Figure 3D ). Based on these results, we proceeded to the survival study.
| B. Nine survival procedures
Seven of the 9 survival recipients were successfully weaned from ventilation support and returned to their cages within 24 hours after revascularization of porcine lung grafts. In 2 cases (14P27 and 14P50), the recipients were euthanized at 25 and 28 hours, respectively, post-reperfusion, due to accelerated acute humoral rejection, which was confirmed by pathologic examination (details in the next section). Seven baboons were extubated and brought to their usual cages, without any special oxygen support. Although others have reported a high incidence of unsuccessful weaning from ventilators due to pulmonary or tracheal edema, 35 we did not experience this complication. Survival of these 7 lung xenografts was 5 days of the excised grafts showed diffuse hemorrhage ( Figure 4E-1, 2 ).
The remaining animals, #11P67 and #12P79, developed continuous coughing and hemosputum 1 day prior to euthanasia. In addition, the chest tube output increased to >100 mL/24 hours, and the effusion became dark, indicating that the graft was severely rejected. The lung graft in both cases showed severe hemorrhagic change ( Figure 4F-1, 2) . Because of severe hemorrhagic and necrotic changes, immunohistologic assessment for antibody deposits was not reliable due to high background.
In contrast, the remaining 3 animals, #14P4, #13P17, and #13P44, survived for >7 days: >7, 9, and 10 days. #14P4 showed no respiratory symptoms after XLTx. The animal developed lower extremity edema due to a femoral line occlusion (attributed to the crystal formation associated with MMF infusion) on POD 6, necessitating euthanasia on POD 7. On POD 7, the chest X-ray showed that had also a stable clinical course through POD 6. The chest X-ray on POD 7, when a cough developed, showed that the lower lobe was partially aerated and the upper lobe was completely collapsed ( Figure 6A ). Gross examination through a left thoracotomy also confirmed the partially aerated lower lobe ( Figure 6B ). Blood gas from the graft PV was 400 mm Hg with a FiO2 of 100%. The small biopsy specimen from the edge of the lung graft was not viable. A second full examination was performed on POD 9, at which point the lung graft was severely congested and blood could not be obtained from the PV. Histology showed complete rejection of the lung on POD 9 ( Figure 6C ), and a frozen section showed IgM, IgG, C3, and C5b deposits, indicating humoral rejection ( Figure 6D ). These data thus indicate that rejection likely started on POD 7, with complete rejection by POD 9.
The other animal, #13P44, had no respiratory symptoms after XLTx throughout the entire experimental period and did not reject the graft completely even by POD 10. The chest X-ray on POD 7
showed a well-aerated lower lobe, but the upper lobe was collapsed, as subsequently confirmed by the gross examination through a left thoracotomy. PV blood gas from the graft at that time showed a PaO2 of 400 mm Hg. Histology on POD 7 showed well-aerated alveolar spaces although focal microthrombi (arrow in Figure 7A) were observed. The animal remained stable in the cage after the POD 7 biopsy, and the second full examination through left thoracotomy was performed on POD 10. Despite only partial aeration of 
| C. Baboon anti-pig antibodies (Abs) following XLTx in all 11 recipients
All recipients had pre-formed anti-pig non-Gal NAb, predominantly
IgM, assessed by FCM ( Figure 7D 1-11) . The fluorescence intensity of anti-pig IgM decreased at POD 2, suggesting that anti-NAb were adsorbed by lung grafts ( Figure 7D ). However, we did not detect elicited anti-pig non-Gal Ab in the sera from any of the recipients, including those receiving lungs from GalT-KO alone and those receiving GalT-KO/hCD47/hCD55 XLTx. Elicited anti-pig Ab may have accumulated in the rejected hemorrhagic grafts and thus have not been detectable in sera.
| D. Factors involved in avoiding the early loss of lung grafts
To examine factors that might play a role in avoiding the early loss of lung grafts, we constructed a table based on survival (Table 1) .
We divided animals into 2 subgroups: (Subgroup A) survival >7 days with aerated lungs (n = 3); (Subgroup B) complete rejection of lung grafts by POD 7 (n = 8). We also characterized transgene expression F I G U R E 3 A, Systolic blood pressure and SpO2 of #13P85. Systolic blood pressure was > 90 mm Hg, and SpO2 was constantly >95%; B, CBC data during the experiment. Although 3 pRBC transfusions (*) were required due to anemia, WBC and platelets were stable; C, PaO2 of systemic arterial blood gas and graft PV blood gas. The PaO2 of both was of good value until the end of the experiment; D, Gross finding of the lung graft at 72 h and H&E findings of lung graft at 2, 24, 48, and 72 h after Tx. Although some superficial congestion due to atelectasis from compression by chest wall was found, the lung graft was well expanded and perfused grossly. Hemorrhagic change, congestion, and microthrombi increased with time. However, there were still expanded alveoli and patent vessels 72 h after revascularization in donor lungs by examining the contralateral, right naïve lung tissues of donor pigs immunohistologically.
| (1) hCD47 expression in both alveoli and vessels in donor lungs may play an important role in prolonging xeno-lung graft survival
To confirm transgenic expression in donor lungs, contralateral right naïve lung tissues of donor pigs were collected and stained with antihuman CD39, hCD46, hCD47, hCD55, TBM, and EPCR (Table 1 ). 
| Subgroup
| Subgroup B: Cases of complete rejection of the lung grafts by POD 7 (n = 8)
In contrast to Group 1, none of contralateral naïve lungs in Group 2 had hCD47 expression in vessels (Table 1) 
| (2) Cytotoxicity levels of pre-formed antinon-Gal natural antibody (NAb)
All recipients were screened for levels of cytotoxic pre-formed NAb ( 
| (3) Cotransplantation of pig VTLs
Five of 9 baboons under the survival protocol received VTL grafts simultaneously with the lung Tx, as part of a tolerance-inducing strategy that we have previously studied extensively in our kidney xenograft models. 15, 26 Unfortunately, 2 cases were not well vascularized soon after revascularization (ie, technical failures). The other 3 VTL grafts turned pink immediately after revascularization (Table 1) . We did not observe prolongation of survival of lung grafts by VTL grafts simultaneously transplanted. However, although excised lung grafts were rejected at 28 hours (14P50), POD 7 (12P79) and POD 9 (13P17), all 3 VTL grafts were found to be viable at necropsy, suggesting that a unique immunologic barrier, not present for thymus, led the early graft loss of lungs. H&E findings of these VTL grafts showed the well-maintained thymic structure of the medulla and cortex ( Figure 9A ). Cell populations of VTLs excised at POD 7 or POD 9 were examined by both histologic and FCM analyses and 
| Discussion
We report here >7-day survival with the histologic evidence of viable lung xenografts. Immunohistologic analysis of donor lungs demonstrated hCD47 expression both on endothelium and on alveolar epithelium only in lungs from donors that survived >7 days.
All other donor lungs lacked endothelial hCD47 expression and were completely rejected by POD 6. In addition, we observed the acceptance of a vascularized thymic graft without hCD47 expression in a baboon that lost its lung xenograft. Our data suggest that a unique immunologic environment exists in lungs and that hCD47 expression in both alveoli and vessels may play an important role in prolonging lung xenograft survival. To our knowledge, this is the first evidence of histologically viable porcine lung grafts beyond 7 days in baboons and the first demonstration that GalT-KO pig lungs undergo acute humoral rejection, to which they may be uniquely susceptible. Our data suggest that this early humoral rejection may be mitigated by transgenic expression of hCD47.
Although the number of animals studied in this report is relatively small, it is noteworthy that among the 9 survival procedures, all 3 lung xenotransplants utilizing donors expressing hCD47 in their lung vessels survived greater than 7 days with aerated lungs.
In contrast, other donors, not expressing hCD47 in pulmonary vessels (Table 1) , underwent severe rejection, associated with diffuse hemorrhage. Although additional animals are required to draw firm conclusions, the presented data suggest that expression of hCD47
in pig donor lung vessels may be important for the protection of the lung grafts during the early post-transplant period.
Another potentially important finding was split acceptance of a VTL graft in the baboon that lost its xenograft lung at POD 7 or POD 9, suggesting a unique immunologic environment in lungs, as previous studies of kidney plus VTL grafts showed comparable survivals of both organs. 30, 37 Indeed, we have previously demonstrated that cotransplantation of a pig vascularized thymus, either as TK or as VTLs, markedly prolonged survival of pig kidneys in baboon recipients, compared with transplantation of kidneys alone. 26 In contrast, the porcine lung in baboon #12P79 was clearly rejected, despite the fact that the VTL graft from the same GalT-KO donor (Pig-23945) was viable and functioning, with the evidence of well-preserved thymic structure with early recipient baboon thymopoiesis. A possible explanation for this dichotomy of organ survival relates to the fact that the mammalian pulmonary capillaries are extremely thin.
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Additionally, an inherently more robust innate immune response may exist within the lung due to its barrier function. [39] [40] [41] The alveolar capillary network may thus be particularly susceptible to endothelial activation or destruction associated with innate responses, including the effects of pre-formed NAb.
Our data, along with previous data in vitro and in vivo, 42, 43 are consistent with the hypothesis that species incompatibility of CD47 and its ligand, SIRPα, may play an important role in the early destruction of endothelium in the alveolar network, resulting in hemorrhagic changes in lung grafts. In the present study, the lung grafts of both recipients surviving >7 days expressed hCD47 not only on alveolar epithelium but also on the endothelium, while all other lungs lacked hCD47 expression on the endothelium, despite the expression of hCD47 in alveoli. These results are also consistent with findings from this laboratory on the role of limited cross-species reactivity of CD47-SIRPα interactions 44 and on the ability of transgenic hCD47 to prevent xenograft rejection by suppressing phagocytosis of donor cells.
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Based on our results along with other reports described above, pre-formed anti-non-Gal cytotoxicity is likely a synergistic factor, but not the sole mechanism of the early destruction of the alveolar network. Thus, human macrophages can phagocytose porcine cells even in the absence of Ab or complement activation. 45 In addition, low cytotoxic levels of pre-formed anti-pig Ab do not induce accelerated rejection of heart or kidney xenotransplants in GalT-KO pig-to-NHP models. 9, 46, 47 Taken together, these studies suggest a mechanism in which destruction of the fragile structure of alveolar capillary endothelium by pre-formed NAb, even at low level, combined with macrophage activation and/or phagocytosis of endothelial cells caused by CD47-SIRPα incompatibility, leads to diffuse hemorrhage in the grafts. Therefore, expression of hCD47 on vascular endothelium in lungs may be essential for the prevention of early destruction of the alveolar network across this xenogeneic barrier.
One of 4 Revivicor hCD46/hCD47 GalT-KO swine showed hCD47 expression in pulmonary vessels, but the others did not.
Although all Revivicor pigs were produced by cloning, and using an identical GalT-KO/CD46 background, 2 different founder animals with different CD47 integration events were used. While all demonstrated hCD47 expression in the lung, the line that expressed hCD47 specifically in pulmonary vessels was not an identical clone to the other three. The Sachs/Columbia hCD47/hCD55 Tg GalT-KO miniature swine were naturally produced from source pigs (Table   S1 ). Although F1 and F2 donors were descendants of 2 clonal generation founders, both of which were produced by nuclear transfer from the same cloned fetal cell line, transgenic donors in this study showed different expression patterns of hCD47 and hCD55 in the lungs (Table 1 ). This differs from the consistently low expression of hCD47 and consistently moderate expression of hCD55 observed in PBMC of this Tg line (not shown). Aside from global differences in gene expression between cloned and naturally produced animals, 48 transgenes introduced by other methods have been shown to exhibit epigenetic variability of expression. Epigenetic differences in expression can be dependent on genetic background and require multiple passages of the transgene through the germline for stabilization. 49 The results presented here further emphasize the need for transgene expression monitoring, even in early generations of naturally produced source pigs.
In summary, the key new finding reported here is the high sensitivity of lung xenografts to antibody-mediated rejection.
All 3 lung xenografts that expressed hCD47 in the lungs at both alveolar and vascular levels (on both endothelial cells and median layers) survived ≥7, 9, and 10 days, with no histologic evidence of rejection for over 7 days. In contrast, all lung grafts F I G U R E 7 (A) H&E finding of the lung graft of #13P44 at POD 7. Well-aerated alveolar spaces with focal microthrombi were observed. (B) H&E finding of the lung graft of #13P44 at POD 10 revealed that aerated area remained approximately 50% of lower lobe, while hemorrhagic changes developed. (C) Immunofluorescence staining of IgM (C-1), IgG (C-2), C3 (C-3), and C5b (C-4) of the lung graft of 13P44 at POD 10. Deposition of anti-pig IgM was detected but not IgG, C3, or C5b. (D) Anti-non-Gal antibody levels of baboon recipients assessed by FCM from pre-XLTx until the end of the experiment: (1) #14P4, (2) #13P17, (3) #13P44, (4) #12P79, (5) #11P67, (6) #12P53, (7) #12P78, (8) #13P85, (9) #13P64, (10) #14P50, and (11) #14P27 by FCM. All recipients had pre-formed anti-pig non-Gal NAb. However, no elicited antipig non-Gal Ab was observed in sera from any of recipients not expressing hCD47 at these levels in this study were rejected by POD 7 with hemorrhagic changes. Collectively, our results suggest that GalT-KO pig lungs are highly susceptible to acute vascular rejection that can be mitigated, but not totally avoided, by transgenic expression of hCD47 in donor lungs. It is therefore clear that further strategies will be required to prolong lung graft 
CD201 (EPCR) hCD39
survival from days to months. To protect the alveolar capillary network, in addition to adding hCD47 and other vascular protective genes as well as genes to reduce antigens against non-Gal Abs, 50 strategies to minimize inflammatory responses caused by pre-formed Nab, macrophages, NK cells, T cells, and B cells must be considered prior to XLTx. We are currently exploring delayed lung transplantation in recipients that have received toleranceinducing preconditioning with lung-specific strategies. We have previously reported that intrabone bone marrow (IBBM) Tx in a GalT-KO pig-to-baboon model allowed pig BM cells to engraft for over 28 days in a baboon, resulting in the induction of donor-specific unresponsiveness in vitro and prolonged survival of a xeno-kidney. 33 We have also previously reported that fully allogeneic porcine VTL grafts in recipients treated with 28 days of tacrolimus facilitated induction of tolerance of VTL-matched kidneys that were transplanted 3 months after VTL grafts without immunosuppression in a swine model. 23 We will now combine these delayed XLTx strategies with a tolerance-inducing preconditioning regimen which includes lung-specific treatments 29 , as well as utilizing new TGs donors 50 to determine whether they will overcome the unique immunologic barriers in XLTx.
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